Ben Cohen, PhD, MPH is the Director of HEOR at Stage Analytics, after serving in various roles at Stage over the last several years. He earned a PhD in Pharmaceutical and Health Economics at the University of Southern California School of Pharmacy. His dissertation work focused on evaluating the costs and benefits of spending in chronic diseases using administrative claims, microsimulations, and survey data. Previously, he received an MPH from Columbia University Mailman School of Public Health. Prior to joining Stage, he gained extensive industry experience working in major biopharma.
At Stage Analytics, our health economics & outcomes research (HEOR) services help clients develop, support, and communicate the value of their innovations – throughout the entire product development process. From the very early clinical development stages to post-approval and market access phases, we are your partner to strategize and support your evidence generation efforts at every stage of the journey.
At Stage Analytics, we help our clients reach their unique research, commercial, and market access goals through our customized health economics & outcomes research (HEOR) solutions. We combine scientific and academic rigor with personalized project management services to generate credible, fit-for-purpose deliverables that bring significant value to our clients. Our epidemiologic, economic, and outcomes research capabilities employ advanced methods and clinical expertise to effectively and reliably communicate product value to payers, HTA agencies, healthcare organizations, providers, and other key stakeholders.
